FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380372844> ?p ?o ?g. }

• W4380372844 endingPage "1709" @default.
• W4380372844 startingPage "1709" @default.
• W4380372844 abstract "Oxyresveratrol (ORV) is one of the novel antioxidants having been extensively studied in recent years. One of the main sources of ORV is Artocarpus lakoocha, which has been used in traditional medicine in Thailand for decades. However, the role of ORV in skin inflammation has not been clearly demonstrated. Therefore, we investigated the anti-inflammatory effects of ORV on dermatitis model. The effect of ORV was examined on human immortalized and primary skin cells exposed to bacterial components including peptidoglycan (PGN) and lipopolysaccharide (LPS) and 2,4-Dinitrochlorobenzene (DNCB)-induced dermatitis mouse model. PGN and LPS were used to induce inflammation on immortalized keratinocytes (HaCaT) and human epidermal keratinocytes (HEKa). We then performed MTT assay, Annexin V and PI assay, cell cycle analysis, real-time PCR, ELISA and Western blot in these in vitro models. H&E staining, immunohistochemistry (IHC) staining with CD3, CD4 and CD8 markers were used to evaluate the effects of ORV in in vivo model of skin inflammation using BALB/c mice. Pretreatment of HaCaT and HEKa cells with ORV inhibited pro-inflammatory cytokine production through inhibition of NF-κB pathway. In DNCB-induced dermatitis mouse model, ORV treatment reduced lesion severity, and skin thickness and numbers of CD3, CD4 and CD8 T cells in the sensitized skin of mice. In conclusion, it has been demonstrated that ORV treatment can ameliorate inflammation in the in vitro models of skin inflammation and in vivo models of dermatitis, suggesting a therapeutic potential of ORV for treatment of skin diseases particularly eczema." @default.
• W4380372844 created "2023-06-13" @default.
• W4380372844 creator A5004879421 @default.
• W4380372844 creator A5013883198 @default.
• W4380372844 creator A5016611718 @default.
• W4380372844 creator A5018426072 @default.
• W4380372844 creator A5022806298 @default.
• W4380372844 creator A5036411113 @default.
• W4380372844 creator A5044447529 @default.
• W4380372844 creator A5064773507 @default.
• W4380372844 creator A5066719520 @default.
• W4380372844 date "2023-06-12" @default.
• W4380372844 modified "2023-09-30" @default.
• W4380372844 title "Oxyresveratrol Attenuates Inflammation in Human Keratinocyte via Regulating NF-kB Signaling and Ameliorates Eczematous Lesion in DNCB-Induced Dermatitis Mice" @default.
• W4380372844 cites W1969260205 @default.
• W4380372844 cites W1977961072 @default.
• W4380372844 cites W1984525156 @default.
• W4380372844 cites W1985941510 @default.
• W4380372844 cites W1986713463 @default.
• W4380372844 cites W1987844651 @default.
• W4380372844 cites W2008810664 @default.
• W4380372844 cites W2014666581 @default.
• W4380372844 cites W2015733769 @default.
• W4380372844 cites W2021420535 @default.
• W4380372844 cites W2029331076 @default.
• W4380372844 cites W2034950600 @default.
• W4380372844 cites W2036476778 @default.
• W4380372844 cites W2054488604 @default.
• W4380372844 cites W2094801500 @default.
• W4380372844 cites W2106173959 @default.
• W4380372844 cites W2111808019 @default.
• W4380372844 cites W2130835116 @default.
• W4380372844 cites W2143938651 @default.
• W4380372844 cites W2171005142 @default.
• W4380372844 cites W2174132185 @default.
• W4380372844 cites W2337268419 @default.
• W4380372844 cites W2465799764 @default.
• W4380372844 cites W2594455611 @default.
• W4380372844 cites W2594626272 @default.
• W4380372844 cites W2625241588 @default.
• W4380372844 cites W2735527928 @default.
• W4380372844 cites W2776079342 @default.
• W4380372844 cites W2787696154 @default.
• W4380372844 cites W2897553060 @default.
• W4380372844 cites W2909636648 @default.
• W4380372844 cites W2919640881 @default.
• W4380372844 cites W2920206917 @default.
• W4380372844 cites W2969968065 @default.
• W4380372844 cites W2980466108 @default.
• W4380372844 cites W29902740 @default.
• W4380372844 cites W3080522135 @default.
• W4380372844 cites W3158977859 @default.
• W4380372844 cites W3190612834 @default.
• W4380372844 cites W4200278185 @default.
• W4380372844 cites W4376126975 @default.
• W4380372844 doi "https://doi.org/10.3390/pharmaceutics15061709" @default.
• W4380372844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37376157" @default.
• W4380372844 hasPublicationYear "2023" @default.
• W4380372844 type Work @default.
• W4380372844 citedByCount "0" @default.
• W4380372844 crossrefType "journal-article" @default.
• W4380372844 hasAuthorship W4380372844A5004879421 @default.
• W4380372844 hasAuthorship W4380372844A5013883198 @default.
• W4380372844 hasAuthorship W4380372844A5016611718 @default.
• W4380372844 hasAuthorship W4380372844A5018426072 @default.
• W4380372844 hasAuthorship W4380372844A5022806298 @default.
• W4380372844 hasAuthorship W4380372844A5036411113 @default.
• W4380372844 hasAuthorship W4380372844A5044447529 @default.
• W4380372844 hasAuthorship W4380372844A5064773507 @default.
• W4380372844 hasAuthorship W4380372844A5066719520 @default.
• W4380372844 hasBestOaLocation W43803728441 @default.
• W4380372844 hasConcept C118995209 @default.
• W4380372844 hasConcept C136764020 @default.
• W4380372844 hasConcept C150903083 @default.
• W4380372844 hasConcept C185592680 @default.
• W4380372844 hasConcept C202751555 @default.
• W4380372844 hasConcept C203014093 @default.
• W4380372844 hasConcept C207001950 @default.
• W4380372844 hasConcept C2776555147 @default.
• W4380372844 hasConcept C2776914184 @default.
• W4380372844 hasConcept C2777074287 @default.
• W4380372844 hasConcept C2777459323 @default.
• W4380372844 hasConcept C2778702967 @default.
• W4380372844 hasConcept C2778754761 @default.
• W4380372844 hasConcept C2780599195 @default.
• W4380372844 hasConcept C2781092759 @default.
• W4380372844 hasConcept C41008148 @default.
• W4380372844 hasConcept C54355233 @default.
• W4380372844 hasConcept C55493867 @default.
• W4380372844 hasConcept C71924100 @default.
• W4380372844 hasConcept C71928629 @default.
• W4380372844 hasConcept C86803240 @default.
• W4380372844 hasConcept C98274493 @default.
• W4380372844 hasConceptScore W4380372844C118995209 @default.
• W4380372844 hasConceptScore W4380372844C136764020 @default.
• W4380372844 hasConceptScore W4380372844C150903083 @default.
• W4380372844 hasConceptScore W4380372844C185592680 @default.
• W4380372844 hasConceptScore W4380372844C202751555 @default.

• next